Australija - anglų - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; mannitol; sodium hydroxide - frusemide high dosage formulations are intended exclusively for patients with severely impaired renal function. use under strict medical supervision only within a hospital setting (see dosage and administration). high doses of frusemide may be used as an adjuvant treatment of oliguria and in the promotion of diuresis in the treatment of oedema; in selected patients with acute renal failure, e.g. in the post-operative phase and in association with septic infections; in selected patients with chronic renal failure with fluid retention, both in the pre-dialysis phase and when dialysis has become unavoidable, especially in the presence of acute pulmonary oedema; in selected patients with the nephrotic syndrome with severe impairment of renal function, e.g. in chronic glomerular nephritis, lupus erythematosus and kimmelstiel-wilson syndrome. if diuresis is less than 2.5 l/day, dialysis has to be used.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - gentamicin sulfate 10 mg/ml (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) - solution for infusion - 10 mg/ml - active: gentamicin sulfate 10 mg/ml (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) excipient: disodium edetate dihydrate sodium hydroxide sulfuric acid water for injection - dbl™ gentamicin injection bp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa proteus species (indole positive and indole negative) escherichia coli klebsiella - enterobacter - serratia species staphylococcus species (coagulase positive and coagulase negative) dbl™ gentamicin injection bp should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia respiratory tract infections infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis urinary tract infections (recurrent, complicated) dbl™ gentamicin injection bp is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. dbl™ gentamicin injection bp may be considered as initial therapy in suspected or confirmed gram negative infections and therapy may be instituted before obtained results of susceptibility testing. if anaerobic organisms are suspected, additional antimicrobial therapy should be added to the gentamicin regime.

Airija - anglų - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - cisatracurium - solution for injection/infusion - 2 milligram(s)/millilitre - other quaternary ammonium compounds; cisatracurium

Airija - anglų - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - furosemide - solution for injection - 20 mg/2ml - sulfonamides, plain; furosemide

Airija - anglų - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - furosemide - solution for injection - 50 mg/5ml - sulfonamides, plain; furosemide

Airija - anglų - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - furosemide - solution for injection - 10 milligram(s)/millilitre - sulfonamides, plain; furosemide

Airija - anglų - HPRA (Health Products Regulatory Authority)

ibigen srl - rocuronium bromide - solution for injection/infusion - 10 milligram(s)/millilitre - other quaternary ammonium compounds; rocuronium bromide

Airija - anglų - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - milrinone - solution for injection/infusion - 1 milligram(s)/millilitre - phosphodiesterase inhibitors; milrinone

Airija - anglų - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - cisatracurium besilate - solution for injection/infusion - 2 milligram(s)/millilitre - other quaternary ammonium compounds; cisatracurium

Airija - anglų - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - furosemide - solution for injection - 10 milligram(s)/millilitre - sulfonamides, plain; furosemide